Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Features of Severe Patients With COVID-19

NCT04450017 is registered in ClinicalTrials.gov with Federal Research Clinical Center of Federal Medical & Biological Agency, Russia as lead sponsor.

NCT NCT04450017
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04450017 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Features of Severe Patients With COVID-19
Lead sponsor
Federal Research Clinical Center of Federal Medical & Biological Agency, Russia
Phase
Observational
Overall status
Completed
Start date
April 6, 2020
Completion date
June 30, 2020
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sars-cov2